Detalhe da pesquisa
1.
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Antimicrob Agents Chemother
; 66(8): e0065722, 2022 08 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35876579